Pregnancy and rheumatoid arthritis: Insights into the immunology of fetal tolerance and control of autoimmunity

Current Rheumatology Reports

Volumn 13, Issue 5, 2011, Pages 449-455

  Amin, Shreyasee ^a   Peterson, Erik J ^b   Reed, Ann M ^a   Mueller, Daniel L ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Autoimmunity; HLA G; Immune tolerance; Pregnancy; Regulatory T lymphocytes; Rheumatoid arthritis

Indexed keywords

ARTICLE; AUTOIMMUNITY; DISEASE ACTIVITY; DISEASE EXACERBATION; FEMALE; FETAL TOLERANCE; FETUS; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; MEAN CORPUSCULAR HEMOGLOBIN; PREGNANCY; PUERPERIUM; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; FEMALE; FETUS; HUMANS; IMMUNE TOLERANCE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 80755133569     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-011-0199-1     Document Type: Article

References (50)

1. Hench PS. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis and intermittent hydrarthrosis. Mayo Clin Proc. 1938;13:161-7.
2. Nelson JL, Ostensen M. Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am. 1997, 23(1):195-212. (Pubitemid 27089264)
3. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31(3):315-24. (Pubitemid 18091653)
4. de Man YA, Hazes JMW, van de Geijn FE, et al. Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis. Arthritis Rheum. 2007, 57(5):716-22. (Pubitemid 46932075)
5. • de Man YA, Dolhain RJEM, van de Geijn FE, et al. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008, 59(9):1241-8. This is a large, prospective study investigating the effects of pregnancy on RA disease activity.
6. Barrett JH, Brennan P, Fiddler M, Silman AJ. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum. 1999, 42(6):1219-27. (Pubitemid 29268959)
7. Nelson JL, Hughes KA, Smith AG, et al. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med. 1993, 329(7):466-71. (Pubitemid 23222332)
8. Norgaard M, Larsson H, Pedersen L, et al. Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med. 2010, 268(4):329-37.
9. de Man YA, Hazes JMW, van der Heide H, et al. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum. 2009, 60(11):3196-206.
10. Ostensen M, Villiger PM. The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol. 2007, 29(2):185-91. (Pubitemid 47596395)
11. Elenkov IJ. Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci. 2004;1024:138-46. (Pubitemid 38879598)
12. Ostensen M: Glucocorticosteroids in pregnant patients with rheumatoid arthritis. Zeitschrift fur Rheumatologie 2000;59 SUPPL. 2:II/70-4.
13. Zen M, Ghirardello A, Iaccarino L, et al. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly 2010;140(13-14):187- 201.
14. Doria A, Iaccarino L, Arienti S, et al. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol. 2006, 22(2):234-41. (Pubitemid 43994383)
15. Cutolo M, Brizzolara R, Atzeni F, et al. The immunomodulatory effects of estrogens: clinical relevance in immune-mediated rheumatic diseases. Ann N YAcad Sci. 2010;1193:36-42.
16. Cutolo M, Capellino S, Straub RH: Oestrogens in rheumatic diseases: friend or foe? Rheumatology 2008;47 SUPPL. 3:iii2-5.
17. Piccinni MP, Giudizi MG, Biagiotti R, et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol. 1995, 155(1):128-33.
18. Ostensen M, Forger F, Villiger PM. Cytokines and pregnancy in rheumatic disease. Ann N YAcad Sci. 2006;1069:353-63. (Pubitemid 43989878)
19. Forger F, Ostensen M. Is IgG galactosylation the relevant factor for pregnancy-induced remission of rheumatoid arthritis? Arthritis Res Ther. 2010, 12(1):108.
20. van Zeben D, Rook GA, Hazes JM, et al. Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study. Br J Rheumatol. 1994, 33(1):36-43. (Pubitemid 24042034)
21. Rook GA, Steele J, Brealey R, et al. Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J Autoimmun. 1991, 4(5):779-94.
22. van de Geijn FE, Wuhrer M, Selman MH, et al. Immunoglobulin G galactosylation and sialylation are associated with pregnancyinduced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res Ther. 2009;11(6):R193.
23. Billington WD. The immunological problem of pregnancy: 50 years with the hope of progress. A tribute to Peter Medawar. J Reprod Immunol. 2003, 60(1):1-11. (Pubitemid 37272291)
24. van Nieuwenhoven AL Veenstra, Heineman MJ, Faas MM. The immunology of successful pregnancy. Hum Reprod Update. 2003, 9(4):347-57. (Pubitemid 36987283)
25. Chaouat G The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol. 2007, 29(2):95-113.
26. • Guerin LR, Prins JR, Robertson SA: Regulatory Tcells and immune tolerance in pregnancy: a new target for infertility treatment? Human Reproduction Update 2009;15(5):517-35. This is an excellent review on immune tolerance during pregnancy and the role of Tregs.
27. Coady MA, Mandapati D, Arunachalam B, et al. Dominant negative suppression of major histocompatibility complex genes occurs in trophoblasts. Transplantation. 1999, 67(11):1461-7. (Pubitemid 29282990)
28. Ranella A, Vassiliadis S, Mastora C, et al. Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells. Hum Immunol. 2005, 66(1):43-55. (Pubitemid 40037710)
29. King A, Boocock C, Sharkey AM, et al. Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast. J Immunol. 1996, 156(6):2068-76. (Pubitemid 26087436)
30. King A, Hiby SE, Gardner L, et al.: Recognition of trophoblast HLA class I molecules by decidual NK cell receptors-a review. Placenta 2000;21 SUPPL. A: S81-5.
31. Menier C, Rouas-Freiss N, Favier B, et al. Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule. Tissue Antigens. 2010, 75(3):201-6.
32. Bainbridge DR, Ellis SA, Sargent IL. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol. 2000, 48 (1):17-26.
33. Shakhawat A, Shaikly V, Elzatma E, et al. Interaction between HLA-G and monocyte/macrophages in human pregnancy. J Reprod Immunol. 2010, 85(1):40-6.
34. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986, 136(7):2348-57. (Pubitemid 16136806)
35. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today. 1993, 14(7):353-6. (Pubitemid 23198169)
36. Romagnani S. Lymphokine production by human Tcells in disease states. Annu Rev Immunol. 1994;12:227-57.
37. Saito S, Shiozaki A, Sasaki Y et al. Regulatory T cells and regulatory natural killer (NK) cells play important roles in fetomaternal tolerance. Semin Immunopathol. 2007, 29(2):115-22. (Pubitemid 47596391)
38. Bluestone JA, Kuchroo V Autoimmunity-editorial overview. Curr Opin Immunol. 2009, 21(6):579-81.
39. Lee YK, Mukasa R, Hatton RD, Weaver CT Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol. 2009, 21(3):274-80.
40. Zhou XY Bailey-Bucktrout S, Jeker LT, Bluestone JA. Plasticity of CD4(+) FoxP3 (+) T cells. Curr Opin Immunol. 2009, 21 (3):281-5.
41. + Tregs and their role in regulating the immune system.
42. Bettini M, Vignali DAA. Regulatory Tcells and inhibitory cytokines in autoimmunity. Curr Opin Immunol. 2009, 21(6):612-8.
43. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003, 299(5609):1057-61. (Pubitemid 36222930)
44. Leber A, Teles A, Zenclussen AC. Regulatory T cells and their role in pregnancy. Am J Reprod Immunol. 2010, 63(6):445-59.
45. Lo YM, Lau TK, Chan LY et al. Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem. 2000, 46(9):1301-9.
46. Ehrenstein MR, Evans JG, Singh A, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med. 2004, 200(3):277-85. (Pubitemid 39031247)
47. Cao D, van Vollenhoven R, Klareskog L, et al. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther. 2004;6(4):R335-46.
48. •• Forger F, Marcoli N, Gadola S, et al. Pregnancy induces numerical and functional changes of CD4+CD25 high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis. 2008, 67(7):984-90. This is a key study examining the role of T regulatory cells during pregnancy in women with RA. (Pubitemid 351956662)
49. Yan Z, Lambert NC, Ostensen M, et al. Prospective study of fetal DNA in serum and disease activity during pregnancy in women with inflammatory arthritis. Arthritis Rheum. 2006, 54(7):2069-73. (Pubitemid 44051062)
50. Zrour SH, Boumiza R, Sakly N, et al. The impact of pregnancy on rheumatoid arthritis outcome: the role of maternofetal HLA class II disparity. Joint, Bone, Spine: Revue du Rhumatisme. 2010, 77(1):36-40.